Active Ingredient History
Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Aggression (Phase 1/Phase 2)
Alcoholism (Phase 2)
Analgesia (Phase 2)
Antiemetics (Phase 3)
Bariatric Surgery (Phase 4)
Bile Duct Neoplasms (Phase 2)
Brain Injuries, Traumatic (Early Phase 1)
Breast Neoplasms (Phase 4)
Cannabis (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Cervical Intraepithelial Neoplasia (Phase 2)
Cholangiocarcinoma (Phase 2)
Cocaine-Related Disorders (Phase 2)
Colonic Neoplasms (Phase 2/Phase 3)
Colorectal Neoplasms (Phase 3)
COVID-19 (Phase 2)
Depressive Disorder, Major (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Drug Therapy (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Gastroparesis (Phase 3)
General Surgery (Phase 3)
Genital Neoplasms, Female (Phase 3)
Glioblastoma (Phase 1)
Glioma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 4)
Heart Failure (Phase 4)
Hematologic Diseases (Phase 2)
Heroin Dependence (Phase 1)
HIV Infections (Phase 1)
Hypertension (Phase 2)
Laparoscopy (Phase 4)
Leukemia (Phase 4)
Leukemia, Myeloid, Acute (Phase 3)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 4)
Lymphoma, Non-Hodgkin (Phase 1)
Marijuana Abuse (Phase 2)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 3)
Nasopharyngeal Carcinoma (Phase 1)
Nasopharyngeal Neoplasms (Phase 3)
Nausea ()
Neoadjuvant Therapy (Phase 2)
Neoplasms ()
Neoplasms, Germ Cell and Embryonal (Phase 3)
Obesity (Phase 4)
Opioid-Related Disorders (Phase 1)
Ovarian Neoplasms (Phase 4)
Pain, Postoperative (Phase 2)
Pancreatic Neoplasms (Phase 3)
Parkinson Disease (Phase 2)
Postoperative Complications (Phase 4)
Pruritus (Phase 4)
Radiation (Phase 3)
Sarcoma (Phase 2)
Sezary Syndrome (Phase 4)
Stress Disorders, Post-Traumatic (Phase 2)
Substance-Related Disorders (Phase 1)
Substance Withdrawal Syndrome (Phase 1)
Tobacco Use Disorder (Phase 1)
Uterine Cervical Neoplasms (Phase 3)
Uterine Neoplasms (Phase 4)
Vomiting (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue